 Globin chain synthesis myelodysplastic syndromes Globin chain synthesis reticulocytes patients various myelodysplastic syndromes MDS alpha beta globin chain synthetic ratio probable prognostic value mean SD value total alpha beta ratio ratio normal controls difference significant alpha beta ratios normal patients alpha-thalassaemia-like group normal limits group II normal beta-thalassaemia-like group III group FAB subtypes addition exogenous haem several test samples slight increase alpha beta ratios group high risk cases refractory anaemia excess blasts RAEB chronic myelomonocytic leukaemia CMML patients acute non-lyphoid leukaemia ANLL low normal alpha beta ratios significant correlation alpha beta ratios various haematological variables survival MDS alpha beta ratio entire population patients FAB subtype prognostic value haem deficiency cases MDS remains unclear